Literature DB >> 11254643

Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin.

A G Allen1, S Bolitho, H Lindsay, S Khan, C Bryant, P Norton, P Ward, J Leigh, J Morgan, H Riches, S Eastty, D Maskell.   

Abstract

A defined allelic-replacement mutant of the sly gene, encoding a thiol-activated cytolysin, from a European isolate of Streptococcus suis serotype 2 was generated and characterized. Unlike the parental strain, it is nonhemolytic, noncytotoxic for cultured macrophage-like cells, avirulent in a mouse infection model, yet only slightly attenuated in a porcine model of systemic infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254643      PMCID: PMC98215          DOI: 10.1128/IAI.69.4.2732-2735.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  The nature of cell wall-derived inflammatory components of pneumococci.

Authors:  A Tomasz; K Saukkonen
Journal:  Pediatr Infect Dis J       Date:  1989-12       Impact factor: 2.129

2.  Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.

Authors:  N Charland; V Nizet; C E Rubens; K S Kim; S Lacouture; M Gottschalk
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.

Authors:  M Segura; J Stankova; M Gottschalk
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis.

Authors:  A A Jacobs; A J van den Berg; P L Loeffen
Journal:  Vet Rec       Date:  1996-09-07       Impact factor: 2.695

5.  Production of suilysin, the thiol-activated haemolysin of Streptococcus suis, by field isolates from diseased pigs.

Authors:  A A Jacobs; A J van den Berg; J C Baars; B Nielsen; L W Johannsen
Journal:  Vet Rec       Date:  1995-09-16       Impact factor: 2.695

6.  Epithelial invasion and cell lysis by virulent strains of Streptococcus suis is enhanced by the presence of suilysin.

Authors:  P M Norton; C Rolph; P N Ward; R W Bentley; J A Leigh
Journal:  FEMS Immunol Med Microbiol       Date:  1999-10

7.  The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.

Authors:  E Tuomanen; A Tomasz; B Hengstler; O Zak
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

8.  Characterization of Streptococcus suis capsular type 2 haemolysin.

Authors:  M G Gottschalk; S Lacouture; J D Dubreuil
Journal:  Microbiology       Date:  1995-01       Impact factor: 2.777

9.  Partial characterization of Streptococcus suis type 2 hemolysin.

Authors:  I Feder; M M Chengappa; B Fenwick; M Rider; J Staats
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis.

Authors:  I R Friedland; M M Paris; S Hickey; S Shelton; K Olsen; J C Paton; G H McCracken
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

View more
  35 in total

1.  Role of capsule and suilysin in mucosal infection of complement-deficient mice with Streptococcus suis.

Authors:  Maren Seitz; Andreas Beineke; Alena Singpiel; Jörg Willenborg; Pavel Dutow; Ralph Goethe; Peter Valentin-Weigand; Andreas Klos; Christoph G Baums
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Viral Coinfection Replaces Effects of Suilysin on Streptococcus suis Adherence to and Invasion of Respiratory Epithelial Cells Grown under Air-Liquid Interface Conditions.

Authors:  Georg Herrler; Nai-Huei Wu; Peter Valentin-Weigand; Fandan Meng; Jie Tong; Désirée Vötsch; Ju-Yi Peng; Xuehui Cai; Maren Willenborg
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Differentiation of highly virulent strains of Streptococcus suis serotype 2 according to glutamate dehydrogenase electrophoretic and sequence type.

Authors:  Russell Kutz; Ogi Okwumabua
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

4.  Characterization and proteome analysis of inosine 5-monophosphate dehydrogenase in epidemic Streptococcus suis serotype 2.

Authors:  Junming Zhou; Xuehan Zhang; Kongwang He; Wei Wang; Yanxiu Ni; Haodan Zhu; Zhengyu Yu; Aihua Mao; Lixin Lv
Journal:  Curr Microbiol       Date:  2014-01-24       Impact factor: 2.188

5.  Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis.

Authors:  Christoph G Baums; Ute Kaim; Marcus Fulde; Girish Ramachandran; Ralph Goethe; Peter Valentin-Weigand
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

6.  Contribution of fibronectin-binding protein to pathogenesis of Streptococcus suis serotype 2.

Authors:  Astrid de Greeff; Herma Buys; Robin Verhaar; Janny Dijkstra; Loek van Alphen; Hilde E Smith
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  The β-galactosidase (BgaC) of the zoonotic pathogen Streptococcus suis is a surface protein without the involvement of bacterial virulence.

Authors:  Dan Hu; Fengyu Zhang; Huimin Zhang; Lina Hao; Xiufang Gong; Meiling Geng; Min Cao; Feng Zheng; Jin Zhu; Xiuzhen Pan; Jiaqi Tang; Youjun Feng; Changjun Wang
Journal:  Sci Rep       Date:  2014-02-21       Impact factor: 4.379

8.  Identification of an inducible bacteriophage in a virulent strain of Streptococcus suis serotype 2.

Authors:  J Harel; G Martinez; A Nassar; H Dezfulian; S J Labrie; R Brousseau; S Moineau; M Gottschalk
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity.

Authors:  Mariela Segura; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Investigation of a novel DNase of Streptococcus suis serotype 2.

Authors:  Michael C Fontaine; Jose Perez-Casal; Philip J Willson
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.